Association between statin therapy and long-term clinical outcomes in patients with stable coronary disease...

Area of Science:

• Cardiology
• Pharmacology

Background:

• Percutaneous coronary intervention (PCI) is a common procedure for stable coronary artery disease (CAD).
• Long-term clinical outcomes after PCI are influenced by various factors, including medication adherence.
• Statins are widely prescribed to manage cholesterol and reduce cardiovascular risk.

Purpose of the Study:

• To evaluate the long-term impact of statin therapy on clinical outcomes in patients with stable CAD following PCI.
• To identify predictors of all-cause death and major adverse cardiovascular events (MACE) in this patient cohort.

Main Methods:

• Longitudinal cohort study of 1760 patients with stable CAD undergoing PCI.
• Patients were stratified into statin therapy and non-statin therapy groups post-PCI.
• Clinical characteristics, risk factors, angiographic findings, and medications were assessed.
• Cox proportional hazard analysis was used to determine predictors of outcomes.

Main Results:

• The statin group exhibited higher baseline cholesterol and LDL-C levels compared to the non-statin group.
• The non-statin group had significantly higher rates of all-cause death and cardiovascular death.
• Adjusted Cox analysis indicated statin use significantly reduced all-cause death (HR: 0.53) and repeat PCI procedures (HR: 0.69).
• Statin therapy did not significantly reduce the hazard of cardiovascular death or myocardial infarction.

Conclusions:

• Statin therapy following PCI in stable CAD patients is associated with reduced all-cause mortality and fewer repeat PCI procedures.
• While not impacting cardiovascular death or MI risk in this study, statins remain crucial for managing CAD post-PCI.
• Further research may explore optimal statin regimens and their specific impact on different cardiovascular endpoints.